Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Nexalin Technology, Inc. (NXL : NSDQ)
 
 • Company Description   
Nexalin Technology Inc. designs and develops neurostimulation products for mental health epidemic. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. Nexalin Technology Inc. is based in Houston, Texas.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.09 Daily Weekly Monthly
20 Day Moving Average: 68,393 shares
Shares Outstanding: 7.28 (millions)
Market Capitalization: $7.94 (millions)
Beta:
52 Week High: $3.23
52 Week Low: $0.65
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -0.91% 2.29%
12 Week 39.56% 35.79%
Year To Date 45.53% 41.40%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1776 Yorktown Suite 550
-
Houston,TX 77056
USA
ph: 281-830-8900
fax: -
nxl@crescendo-ir.com http://www.nexalin.com
 
 • General Corporate Information   
Officers
Mark White - President and Chief Executive Officer
Marilyn Elson - Chief Financial Officer
Rick Morad - Director
Alan Kazden - Director
Ben Hu - Director

Peer Information
Nexalin Technology, Inc. (EVOL)
Nexalin Technology, Inc. (RAMP)
Nexalin Technology, Inc. (ALOT)
Nexalin Technology, Inc. (TGHI)
Nexalin Technology, Inc. (GNCMA)
Nexalin Technology, Inc. (GSIC)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Technology Services
Sector: Business Services
CUSIP: 65345B201
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/22
Next Expected EPS Date: 03/23/23
Share - Related Items
Shares Outstanding: 7.28
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $7.94 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 03/23/23  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.25
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: 873.74%
vs. Previous Quarter: -%
ROE
12/31/22 - -
09/30/22 - -
06/30/22 - -
ROA
12/31/22 - -
09/30/22 - -
06/30/22 - -
Current Ratio
12/31/22 - -
09/30/22 - 4.21
06/30/22 - -
Quick Ratio
12/31/22 - -
09/30/22 - 4.14
06/30/22 - -
Operating Margin
12/31/22 - -
09/30/22 - -
06/30/22 - -
Net Margin
12/31/22 - -
09/30/22 - -
06/30/22 - -
Pre-Tax Margin
12/31/22 - -
09/30/22 - -
06/30/22 - -
Book Value
12/31/22 - -
09/30/22 - 0.87
06/30/22 - -
Inventory Turnover
12/31/22 - -
09/30/22 - -
06/30/22 - -
Debt-to-Equity
12/31/22 - -
09/30/22 - 0.00
06/30/22 - -
Debt-to-Capital
12/31/22 - -
09/30/22 - 0.00
06/30/22 - -
 

Powered by Zacks Investment Research ©